Social Prescribing: when your GP prescribes singing, gardening, and volunteering

TL;DR: Social prescribing allows doctors to prescribe social, artistic, or community activities in place of — or alongside — medication. The NHS has deployed 3,000 link workers nationally since 2019, with measurable clinical outcomes: a 28% reduction in avoidable GP consultations and a return on investment of £5.92 for every pound spent. Behind it all: loneliness, which increases the risk of premature mortality by 26 to 29% according to a meta-analysis of 3.4 million people.

The scene takes place in a GP surgery in Camden, north London. A patient suffering from chronic anxiety and mild depression has come in for an appointment. The doctor listens, asks a few questions, then writes an unusual prescription: join a choral singing workshop twice a week. No medication. No psychiatric waiting list. A referral to a local community group, and a follow-up appointment in eight weeks.

This is no isolated case. It is now the daily reality of thousands of consultations across the United Kingdom, since social prescribing was embedded in the NHS Long Term Plan in 2019. And behind it lies a question that medicine is only now beginning to take seriously: some health problems will never find their solution in a box of pills.

Loneliness is not a comfort issue — it is a public health crisis

To understand why this practice emerged, we must first name the problem it seeks to address.

A meta-analysis by Holt-Lunstad et al. (2015), covering more than 3.4 million people across 70 studies, reaches an unambiguous clinical finding: social isolation increases the risk of premature mortality by 29%, loneliness by 26%, and living alone by 32%. These figures place isolation on a par with other major risk factors long recognised by medicine.

In the United Kingdom, more than 9 million Britons are affected by loneliness according to the Jo Cox Commission (2016) — which led the British government to appoint a Minister for Loneliness in 2018, a world first. In the United States, the Surgeon General declared an epidemic of loneliness in 2023. In France, the SOLIPAM barometer 2023 estimates 5 million people are in a situation of relational isolation, whilst depression and anxiety represent the second leading cause of sick leave (DREES 2022).

Medication treats the biological symptoms of depression. It does not rebuild a social network. It does not give someone a role within a community. It does not get someone out of their home.

That is precisely the gap that social prescribing seeks to fill.

How does a link worker operate?

The mechanism is straightforward in principle, but its rollout requires real infrastructure.

A link worker is neither a doctor, nor a therapist, nor a social worker in the traditional sense. They are a professional trained in active listening and in knowledge of the local community landscape. When a GP identifies a patient whose symptoms are linked to isolation, lack of physical activity, or loss of purpose, they can refer them to a link worker rather than — or alongside — a medication prescription.

The link worker meets the patient, identifies their interests and barriers, then guides them towards suitable community resources: urban gardening, a cooking group, an arts and crafts workshop, a volunteering programme, a weekly walking group, music classes. They provide follow-up support for three to six months.

NHS England has scaled this practice at a national level: “This is the biggest investment in social prescribing by any national health system and legitimises non-medical community-based activities and holistic support alongside medical treatment as part of a personalised care approach.” The initial target was to deploy 1,000 link workers by 2020–2021, with a goal of 900,000 referrals per year by 2023–2024. Today, the United Kingdom has 3,000 active link workers.

Clinical evidence: what the studies measure

Social prescribing is not a wellness trend dressed up as medicine. It is subject to clinical evaluation.

A systematic review by Polley et al. (2020) analyses 14 studies on the effectiveness of social prescribing: 11 out of 14 show a significant improvement in participants’ mental well-being. The National Academy for Social Prescribing (NASP) confirms “substantial reductions in avoidable GP consultations, hospital admissions, and A&E attendances”. Some evaluations record an average reduction of 28% in GP visits.

On the economic front, the Royal College of General Practitioners and Social Enterprise UK (2021) estimate a return on investment of £5.92 for every pound invested in social prescribing — through savings generated on primary and hospital care.

The NASP specifies that social prescribing is particularly effective for “loneliness, stress, mild to moderate depression, and anxiety” — precisely the conditions most under-served by the conventional healthcare system.

A practice spreading beyond the United Kingdom

The British example has inspired initiatives in several countries.

In Canada, the Canadian Social Prescribing Network has recorded more than 100 programmes since 2019. The approach is carried forward notably by family health teams in Ontario, which integrate a community dimension into primary care consultations.

On the Isle of Man, an evaluation conducted after three months of intervention found that 74% of participants reported a reduction in their sense of isolation.

In France, the practice remains emergent but is progressively taking shape: pilots are under way in five territories, including Angers, Lyon, and Haute-Savoie, as part of a broader movement towards community health and outreach care.

Traditional Okinawa offers, for its part, an illuminating cultural precedent. Moaï — these mutual support groups that Japanese people form from childhood — are practised by approximately 50% of the island’s inhabitants. Women in Okinawa live on average eight years longer than American women — a gap that researchers attribute in part to these long-woven social networks. “Some moaï have lasted more than 90 years,” notes the Blue Zones programme.

What social prescribing cannot do

Social prescribing deserves to be discussed honestly, including its limitations.

The term “prescribing” can be misleading. It is not a medical prescription in the legal sense. Participation is voluntary. In France, there is as yet no reimbursement through the Sécurité sociale, nor any obligation for doctors to offer it.

The risk of medicalising social connection is real. Some researchers sound a warning: transforming what should belong to a natural community fabric into a health service provision may disempower communities and place on the healthcare system problems that are fundamentally political — housing, employment, inequality.

Access is uneven across territories. Large cities have more community resources to draw upon. In rural areas or post-industrial neighbourhoods, a link worker may find themselves referring patients to resources that simply do not exist.

The clinical evidence is still being built. The Polley et al. review notes the diversity of evaluation methods and the difficulty of isolating the specific effect of social prescribing from other factors of recovery. Eleven positive studies out of fourteen is promising — not definitive.

An institutional innovation, not a passing trend

What the NHS has achieved is something rare: integrating a relational practice into a bureaucratic health system, with dedicated funding, professionalised training, and quantified objectives. Without this infrastructure, social prescribing would remain the preserve of a handful of visionary GPs.

Loneliness is not a comfort issue. The epidemiological data have been clear since 2015: it is a major risk factor, comparable to moderate smoking, that cuts across all social classes and generations. Conventional medicine has its limits here — not through incompetence, but because a pill cannot rebuild human connection.

Social prescribing does not claim to solve everything. But it affirms something important: a person’s health is not treated only in a consulting room. It is also built in a community garden, around a kitchen table, in the wings of an amateur theatre production.

That is an idea both ancient and radical.

What you can do:

• If you are a healthcare professional: find out about the community associations in your area. Short training programmes in community referral already exist in several regions.
• If you are going through a period of isolation: local associations (community centres, social centres, mutual aid groups) are often the most accessible entry point. Look for what exists in your area before searching for an individual solution.
• If you are an elected official or community organisation: the connection between community structures and healthcare professionals is still being built in many countries. It is a project that is both open and urgent.

Sources

• Holt-Lunstad et al. 2015 — Loneliness and Social Isolation as Risk Factors for Mortality — verified 2026-05-03
• Holt-Lunstad 2021 — PMC review confirming figures — verified 2026-05-03
• Jo Cox Foundation — Loneliness and social isolation: a new decade of action — verified 2026-05-03
• US Surgeon General Advisory 2023 — Our Epidemic of Loneliness and Isolation — verified 2026-05-03
• NHS England — Social prescribing — verified 2026-05-03
• National Academy for Social Prescribing (NASP) — Evidence reports — verified 2026-05-03
• Blue Zones — Moaï: Okinawa social networks and longevity — verified 2026-05-03
• Polley et al. (2020) — systematic review on social prescribing (11/14 studies, mental well-being improvement) — referenced via editorial brief
• RCGP / Social Enterprise UK (2021) — ROI £5.92 per pound invested — referenced via editorial brief
• SOLIPAM barometer 2023 — 5 million people in relational isolation in France — referenced via editorial brief
• DREES 2022 — depression and anxiety, second leading cause of sick leave in France — referenced via editorial brief